Financials

News Discussions Technicals Seasonals

BIOSGN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Biosergen AB operates as a biopharmaceutical company. It focuses on the clinical development of the antifungal product BSG005, is a potentially disruptive antifungal drug used for the treatment of life threatening invasive fungal disease. The company is headquartered in Solna, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

BIOSGN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company